Corient Private Wealth’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,000
Closed -$164K 2153
2023
Q2
$164K Sell
10,000
-48
-0.5% -$1.98K ﹤0.01% 1911
2023
Q1
$169K Buy
+10,048
New +$423K ﹤0.01% 1818

Other funds holding BME

Corient Private Wealth's BME Position: Q3 2023 in Review

Corient Private Wealth sold out of BlackRock Health Sciences Trust (BME) in Q3 2023, closing a stake of 10,000 shares — an estimated $164K sold.

Corient Private Wealth first reported a position in BME in Q1 2023 and held it in 2 quarters. The position peaked at $169K in Q1 2023. 72 funds tracked by Wall St. Rank hold BME as of Q3 2023.

  • Corient Private Wealth reported no remaining BlackRock Health Sciences Trust position as of Q3 2023 after selling out during the quarter.
  • Corient Private Wealth sold 10,000 BlackRock Health Sciences Trust shares in Q3 2023, an estimated $164K.
  • Corient Private Wealth first reported a position in BlackRock Health Sciences Trust in Q1 2023 and held it in 2 quarters.
  • Corient Private Wealth's BlackRock Health Sciences Trust position peaked at $169K in Q1 2023.
  • 72 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2023.

Based on Corient Private Wealth's 13F filing for Q3 2023, filed 3 Nov 2023.